Thermo Fisher Scientific Inc.
As of Oct 26, 2026 close
- Market cap
- $254.09B
- P/E (TTM)
- 36.41
- Forward P/E
- 34.28
- Dividend yield
- 0.27%
- 52-week range
- $435.27$704.00
- Volume (live)
- -
- Avg. volume (3M)
- 2.49M
Thermo Fisher Scientific (TMO) Stock Price & Financial Analysis
Thermo Fisher Scientific Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $674.37 - $685.48 |
|---|---|
| 52-Week High | $704.00 |
| 52-Week Low | $435.27 |
| Open | $675.86 |
| Volume (last close) | 1.95M |
| Average Volume (3M) | 2.49M |
| Revenue (TTM) | 47.35B |
|---|---|
| Net Income (TTM) | 6.98B |
| Free Cash Flow (TTM) | 7.60B |
| EPS (TTM) | $18.62 |
| Profit Margin | 14.74% |
| Operating Margin | 17.90% |
| Return on Equity (ROE) | 13.25% |
| Debt to Equity | 0.81 |
| Annual Dividend | $1.84 |
|---|---|
| Dividend Yield | 0.27% |
| Payout Ratio | 9.88% |
| Last Dividend Ex-Date | Sep 15, 2026 |
| Market Cap | 254.09B |
|---|---|
| Shares Outstanding | 371.00M |
| P/E Ratio (TTM) | 36.41 |
| Forward P/E | 34.28 |
| Price to Sales (P/S) | 5.37 |
| Price to Book (P/B) | 4.63 |
| EV/EBITDA | 24.09 |
| 50-Day MA | $640.15 |
|---|---|
| 200-Day MA | $548.30 |
| 1-Year Change | +18.29% |
Source: Market prices and company fundamentals. Data as of Oct 26, 2026. Data sources and methodology
Thermo Fisher Scientific at a Glance
As of the Oct 26, 2026 close, Thermo Fisher Scientific (TMO) has a market capitalization of $254.09B. The stock trades at 36.4× trailing earnings, 34.3× forward earnings and 5.4× sales. Over the trailing twelve months it earned $6.98B on revenue of $47.35B (a 14.7% profit margin) and generated $7.60B of free cash flow. Revenue grew 8.3% year over year.
As of its latest reported balance sheet, it holds $5.46B in cash and securities against $42.55B of debt, a net debt position of $37.09B.
Thermo Fisher Scientific pays a quarterly dividend totaling $1.84 per share a year, a 0.27% yield at the Oct 26, 2026 close, with a 10% payout ratio and 8 consecutive years of dividend increases.
The share price is up 18.3% over the past year. At $684.89 (the Oct 26, 2026 close) it sits near the top of its 52-week range of $435.27 to $704.00, above its 200-day moving average of $548.30.
Based on 21 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $752.20, 9.8% above the Oct 26, 2026 close.
Frequently Asked Questions About Thermo Fisher Scientific
What is the current stock price for TMO?
As of the Oct 26, 2026 close, TMO stock trades at $684.89. The 52-week range is $435.27–$704.00, with a day range of $674.37–$685.48.
What is the P/E ratio for TMO?
As of the Oct 26, 2026 close, Thermo Fisher Scientific's trailing twelve-month (TTM) P/E ratio is 36.4, meaning investors pay $36.4 for every $1 of annual earnings. The forward P/E is 34.3, reflecting analyst expectations for future earnings. Thermo Fisher Scientific operates in the Healthcare sector.
Does TMO pay dividends?
Yes, Thermo Fisher Scientific pays a 0.27% annual dividend yield as of the Oct 26, 2026 close ($1.84 per share a year). The trailing twelve-month payout ratio is 9.9%. The most recent ex-dividend date was September 15, 2026.
What do analysts recommend for TMO?
Based on ratings from 21 professional analysts over the last 90 days, the consensus for TMO is Buy. The average 12-month price target is $752.20, a 9.8% upside from the Oct 26, 2026 close of $684.89.
What is the market cap of TMO?
As of the Oct 26, 2026 close, Thermo Fisher Scientific's market capitalization is $254.09B, classifying it as a mega-cap company. Thermo Fisher Scientific operates in the Healthcare sector within the Diagnostics & Research industry.